Exchange: NASDAQ·Updated 07:30 PM EDT

TNDM News

News
all
press releases
Aging Population Drives Healthcare Growth: Stocks to Watch
AbbVie, Tandem Diabetes Care and Amgen are targeting aging-related healthcare growth through advances in immunology, diabetes and cardiovascular care.
Zacks
More News
Can PODD Sustain Growth After Its 2026 Guidance Reset and Q2 Beat?
Insulet's Q2 beat and stronger margins contrast with a 2026 growth reset, putting U.S. Type 2 retention at the center of its outlook.
Zacks
Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics
William Blair initiates coverage on Tandem Diabetes Care and Beta Bionics, highlighting their growth potential in the insulin pump market.read more...
Benzinga
TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up
Tandem Diabetes shares jump 19.1% after a narrower-than-expected Q2 loss, as higher pump shipments and a 57% gross margin offset a slight revenue miss.
Zacks
Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Lags Revenue Estimates
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of +8.82% and -0.10%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks
Tandem Diabetes Care Announces Second Quarter 2026 Financial Results
Tandem Diabetes Care, Inc. (Nasdaq: TNDM) (the Company), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights Sales of $254.6 million worldwide, including $179.3 million in the...
Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentation
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at Canaccord Genuitys 46th Annual Growth Conference on Tuesday, August 11, 2026 at 1:30pm Eastern Time (10:30am Pacific Time). The...
Business Wire
Next-Generation Diabetes Therapies Are Reshaping Healthcare and Creating MultiBillion-Dollar Revenue Opportunities
Breakthrough drugs, AI-powered technologies, and soaring global demand are driving one of healthcare’s fastest-growing markets   New York, NY – July 21, 2026 – Market News Updates News Commentary – Diabetes care is going through one of its biggest transformations in decades. Instead of simply helping patients keep their blood sugar under control, today’s therapies […] The post Next-Generation Diabetes Therapies Are Reshaping Healthcare and Creating MultiBillion-Dollar Revenue Opportunities appeared first on Financial News Media.
Financial News Media
Thursday's ETF Movers: IHI, PTF
In trading on Thursday, the iShares U.S. Medical Devices ETF is outperforming other ETFs, up about 5% on the day. Components of that ETF showing particular strength include shares of Abbott Laboratories, up about 11.7% and shares of Tandem Diabetes Care, up about 8.2% on the da...
Nasdaq News: Markets

Advertisement|Remove ads.